​

Bausch Health Companies (BHC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BHC Stock Forecast

Bausch Health Companies (BHC) stock forecast, based on 32 Wall Street analysts, predicts a 12-month average price target of $10.00, with a high of $10.00 and a low of $10.00. This represents a 96.08% increase from the last price of $5.10.

$5 $6 $7 $8 $9 $10 $11 High: $10 Avg: $10 Low: $10 Last Closed Price: $5.1

BHC Stock Rating

Bausch Health Companies stock's rating consensus is Buy, based on 32 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 20 Buy (62.50%), 11 Hold (34.38%), 1 Sell (3.12%), and 0 Strong Sell (0.00%).

Buy
Total 32 1 11 20 Strong Sell Sell Hold Buy Strong Buy

BHC Price Target Upside V Benchmarks

TypeNameUpside
StockBausch Health Companies96.08%
SectorHealthcare Stocks 35.25%
IndustrySpecialty & Generic Drug Manufacturers Stocks47.55%

Price Target Trends

1M3M12M
# Anlaysts--5
Avg Price Target--$9.00
Last Closing Price$5.10$5.10$5.10
Upside/Downside--76.47%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25--5-16
Mar, 25-15-17
Feb, 25-14-16
Jan, 25-14-27
Dec, 24-15-28
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2024Douglas MiehmRBC Capital$10.00$8.0723.92%96.08%
Jul 25, 2024Les SulewskiTruist Financial$7.00$5.6923.02%37.25%
Jul 10, 2024Michael FreemanRaymond James$8.00$7.1911.27%56.86%
Apr 29, 2024David AmsellemPiper Sandler$9.00$8.782.51%76.47%
Apr 23, 2024Doug MiehmRBC Capital$11.00$8.4530.18%115.69%
Apr 11, 2024Glen SantangeloJefferies$16.00$9.2872.41%213.73%
Apr 05, 2024Doug MiehmRBC Capital$12.00$10.0519.40%135.29%
Sep 09, 2022Piper Sandler$6.00$6.70-10.45%17.65%
Jul 26, 2022RBC Capital$12.00$8.7437.30%135.29%
May 13, 2022RBC Capital$17.00$10.4562.68%233.33%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2024RBC CapitalSector PerformSector Performhold
Aug 01, 2024Piper SandlerNeutralUnderweightdowngrade
Jul 10, 2024Raymond JamesMarket Performinitialise
Apr 29, 2024Piper SandlerNeutralNeutralhold
Apr 08, 2024Cowen & Co.HoldHoldhold
Apr 05, 2024RBC CapitalSector PerformSector Performhold
Mar 28, 2024JefferiesBuyBuyhold
Feb 23, 2024RBC CapitalSector PerformSector Performhold
Sep 09, 2022Piper SandlerNeutralNeutralhold
Jul 26, 2022RBC CapitalOutperformOutperformhold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 $4 $5 $6 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.57$-2.61$-0.59$-1.62$1.10----
Avg Forecast$3.75$4.21$2.97$3.46$3.68$4.13$4.68$4.98$3.54
High Forecast$3.81$4.28$3.02$3.60$3.94$4.57$4.79$5.09$3.62
Low Forecast$3.68$4.13$2.90$3.42$3.50$3.20$4.54$4.83$3.43
Surprise %-141.87%-162.00%-119.87%-146.82%-70.11%----

Revenue Forecast

$8B $8B $9B $9B $10B $11B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.03B$8.43B$8.12B$8.76B$9.52B----
Avg Forecast$8.00B$8.39B$8.05B$8.81B$9.43B$9.67B$9.95B$10.22B$9.13B
High Forecast$8.11B$8.50B$8.16B$8.86B$9.49B$9.82B$10.14B$10.42B$9.29B
Low Forecast$7.88B$8.27B$7.90B$8.76B$9.40B$9.51B$9.75B$10.02B$8.92B
Surprise %0.33%0.51%0.97%-0.55%0.98%----

Net Income Forecast

$-2B $-800M $-100M $600M $1B $2B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-559.00M$-937.00M$-212.00M$-592.00M$-46.00M----
Avg Forecast$-649.22M$-899.13M$-477.55M$-592.00M$1.36B$1.42B$1.70B$1.82B$1.29B
High Forecast$-498.62M$-625.37M$-278.71M$-345.51M$1.44B$1.67B$1.75B$1.86B$1.32B
Low Forecast$-799.81M$-1.17B$-676.40M$-838.49M$1.28B$1.17B$1.66B$1.76B$1.25B
Surprise %-13.90%4.21%-55.61%--103.39%----

BHC Forecast FAQ

Is Bausch Health Companies stock a buy?

Bausch Health Companies stock has a consensus rating of Buy, based on 32 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 20 Buy, 11 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Bausch Health Companies is a favorable investment for most analysts.

What is Bausch Health Companies's price target?

Bausch Health Companies's price target, set by 32 Wall Street analysts, averages $10 over the next 12 months. The price target range spans from $10 at the low end to $10 at the high end, suggesting a potential 96.08% change from the previous closing price of $5.1.

How does Bausch Health Companies stock forecast compare to its benchmarks?

Bausch Health Companies's stock forecast shows a 96.08% upside, outperforming the average forecast for the healthcare stocks sector (35.25%) and outperforming the specialty & generic drug manufacturers stocks industry (47.55%).

What is the breakdown of analyst ratings for Bausch Health Companies over the past three months?

  • April 2025: 0% Strong Buy, 0% Buy, 83.33% Hold, 0% Sell, 16.67% Strong Sell.
  • March 2025: 0% Strong Buy, 14.29% Buy, 71.43% Hold, 0% Sell, 14.29% Strong Sell.
  • February 2025: 0% Strong Buy, 16.67% Buy, 66.67% Hold, 0% Sell, 16.67% Strong Sell.

What is Bausch Health Companies’s EPS forecast?

Bausch Health Companies's average annual EPS forecast for its fiscal year ending in December 2025 is $4.13, marking a 275.45% increase from the reported $1.1 in 2024. Estimates for the following years are $4.68 in 2026, $4.98 in 2027, and $3.54 in 2028.

What is Bausch Health Companies’s revenue forecast?

Bausch Health Companies's average annual revenue forecast for its fiscal year ending in December 2025 is $9.67B, reflecting a 1.58% increase from the reported $9.52B in 2024. The forecast for 2026 is $9.95B, followed by $10.22B for 2027, and $9.13B for 2028.

What is Bausch Health Companies’s net income forecast?

Bausch Health Companies's net income forecast for the fiscal year ending in December 2025 stands at $1.42B, representing a -3184.23% decrease from the reported $-46M in 2024. Projections indicate $1.7B in 2026, $1.82B in 2027, and $1.29B in 2028.